tiprankstipranks

Malcolm Hoenlein Insider Profile

11 Followers
Malcolm Hoenlein, Director at Keryx Biopharma, holds 110.00K shares in Keryx Biopharma (Ticker: KERX), holds 115.75K shares in Fortress Biotech (Ticker: FBIO), holds 78.03K shares in DarioHealth (Ticker: DRIO). Most recently, Malcolm Hoenlein ― shares of Keryx Biopharma on ― for an estimated value of ―.
tipranks
Malcolm Hoenlein

Malcolm Hoenlein
Keryx Biopharma (KERX)
Director

Ranked #35,523 out of 106,487 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+43.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
54.30%
26.11%
19.59%
A breakdown of Malcolm Hoenlein's holdings

Insider Roles

DarioHealth
(DRIO)
Director
Fortress Biotech
(FBIO)
Director
TG Therapeutics
(TGTX)
Former Director
Roles that Malcolm Hoenlein holds in companies

Most Profitable Insider Trade

Stock:
Fortress Biotech
(FBIO)
Rating:Informative Buy
Date:Nov 10, 2014 - Nov 10, 2015
Return:+101.90%
The most profitable trade made by Malcolm Hoenlein

Malcolm Hoenlein's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KERX
Keryx Biopharma
$369.60K
DarioHealth
Jun 08, 2018
Director
Uninformative Buy
$565.74K
Fortress Biotech
Jan 05, 2026
Director
Uninformative Buy
$272.01K
TG Therapeutics
Former Director
$204.13K
List of latest transactions for each holding click on a transaction to see Malcolm Hoenlein's performance on stock

Malcolm Hoenlein insider profile FAQ

What is the percentage of profitable transactions made by Malcolm Hoenlein?
The percentage of profitable transactions made by Malcolm Hoenlein is 50%.
    What is the average return per transaction made by Malcolm Hoenlein?
    The average return per transaction made by Malcolm Hoenlein is 43.80%.
      What stocks does Malcolm Hoenlein hold?
      Malcolm Hoenlein holds: KERX, DRIO, FBIO, TGTX stocks.
        What was Malcolm Hoenlein’s latest transaction?
        Malcolm Hoenlein latest transaction was an Uninformative Buy of ―.
          What was Malcolm Hoenlein's most profitable transaction?
          Malcolm Hoenlein’s most profitable transaction was an Informative Buy of FBIO stock on November 10, 2014. The return on the trade was 101.90%.
            What is Malcolm Hoenlein's role in Keryx Biopharma?
            Malcolm Hoenlein's role in Keryx Biopharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.